UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $23.77 Million Holdings in Amdocs Limited (NASDAQ:DOX)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Amdocs Limited (NASDAQ:DOX - Free Report) by 1,207.3% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 271,701 shares of the technology company's stock after acquiring an additional 250,918 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.23% of Amdocs worth $23,768,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Pzena Investment Management LLC lifted its holdings in Amdocs by 33.2% in the 2nd quarter. Pzena Investment Management LLC now owns 5,667,603 shares of the technology company's stock worth $447,287,000 after purchasing an additional 1,412,826 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its position in Amdocs by 36.6% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,175,790 shares of the technology company's stock worth $277,818,000 after acquiring an additional 851,022 shares during the last quarter. Brandes Investment Partners LP boosted its holdings in Amdocs by 31.1% during the second quarter. Brandes Investment Partners LP now owns 2,260,811 shares of the technology company's stock valued at $178,335,000 after acquiring an additional 536,359 shares during the period. Pacer Advisors Inc. grew its position in shares of Amdocs by 36.2% in the second quarter. Pacer Advisors Inc. now owns 1,675,784 shares of the technology company's stock valued at $132,253,000 after purchasing an additional 444,966 shares during the last quarter. Finally, LSV Asset Management increased its stake in shares of Amdocs by 7.9% in the second quarter. LSV Asset Management now owns 3,207,155 shares of the technology company's stock worth $253,109,000 after purchasing an additional 234,096 shares during the period. 92.02% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages recently issued reports on DOX. StockNews.com lowered shares of Amdocs from a "strong-buy" rating to a "buy" rating in a research report on Thursday, November 14th. Stifel Nicolaus initiated coverage on Amdocs in a research note on Wednesday, October 2nd. They set a "buy" rating and a $100.00 price target on the stock. Barclays decreased their price objective on Amdocs from $113.00 to $111.00 and set an "overweight" rating on the stock in a report on Thursday, November 14th. Finally, Oppenheimer upped their target price on Amdocs from $98.00 to $105.00 and gave the company an "outperform" rating in a research note on Wednesday, November 13th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $101.20.

Amdocs Price Performance

Shares of DOX stock traded down $0.41 during trading hours on Friday, hitting $86.64. The company had a trading volume of 779,784 shares, compared to its average volume of 678,839. Amdocs Limited has a 12 month low of $74.41 and a 12 month high of $94.04. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.24 and a current ratio of 1.20. The firm's fifty day moving average is $88.12 and its 200 day moving average is $84.25. The firm has a market capitalization of $10.18 billion, a price-to-earnings ratio of 20.43, a PEG ratio of 1.46 and a beta of 0.72.

Amdocs Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be given a $0.479 dividend. This represents a $1.92 dividend on an annualized basis and a yield of 2.21%. The ex-dividend date of this dividend is Tuesday, December 31st. Amdocs's dividend payout ratio (DPR) is 45.28%.

Amdocs Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.